Xmark Opportunity Partners, LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Xmark Opportunity Partners, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Xmark Opportunity Partners, LLC. Xmark Opportunity Partners, LLC is 10% Owner in GENAERA CORP ($GENR) and 10% Owner in AEOLUS PHARMACEUTICALS, INC. ($INCR.OB).
Latest Insider Trading Transactions of Xmark Opportunity Partners, LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 33,229 | 12,976 | 10,267,232 | 10.2 M to 10.3 M (+0.32 %) |
| Jan 08 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 20,000 | 7,800 | 10,234,003 | 10.2 M to 10.2 M (+0.20 %) |
| Jan 08 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 10,000 | 3,950 | 10,214,003 | 10.2 M to 10.2 M (+0.10 %) |
| Dec 21 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.23 | 117,659 | 262,309 | 3,935,133 | 3.8 M to 3.9 M (+3.08 %) |
| Dec 21 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.42 | 12,000 | 29,042 | 3,817,474 | 3.8 M to 3.8 M (+0.32 %) |
| Dec 21 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 1.74 | 28,132 | 48,885 | 3,805,474 | 3.8 M to 3.8 M (+0.74 %) |
| Dec 21 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 1.81 | 90,200 | 163,506 | 3,777,342 | 3.7 M to 3.8 M (+2.45 %) |
| Dec 31 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 10,000 | 3,900 | 10,204,003 | 10.2 M to 10.2 M (+0.10 %) |
| Dec 31 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 1,000 | 400 | 10,194,003 | 10.2 M to 10.2 M (+0.01 %) |
| Dec 31 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 16,800 | 6,552 | 10,193,003 | 10.2 M to 10.2 M (+0.17 %) |
| Dec 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.38 | 7,000 | 2,670 | 10,176,203 | 10.2 M to 10.2 M (+0.07 %) |
| Dec 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 11,000 | 4,290 | 10,169,203 | 10.2 M to 10.2 M (+0.11 %) |
| Dec 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 15,000 | 5,951 | 10,158,203 | 10.1 M to 10.2 M (+0.15 %) |
| Dec 10 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.43 | 20,000 | 8,650 | 10,143,203 | 10.1 M to 10.1 M (+0.20 %) |
| Dec 10 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.44 | 30,000 | 13,161 | 10,123,203 | 10.1 M to 10.1 M (+0.30 %) |
| Dec 10 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.45 | 10,000 | 4,540 | 10,093,203 | 10.1 M to 10.1 M (+0.10 %) |
| Dec 04 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.45 | 35,000 | 15,750 | 10,083,203 | 10 M to 10.1 M (+0.35 %) |
| Dec 04 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.45 | 30,000 | 13,500 | 10,048,203 | 10 M to 10 M (+0.30 %) |
| Nov 29 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.41 | 35,000 | 14,452 | 10,018,203 | 10 M to 10 M (+0.35 %) |
| Nov 29 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.42 | 15,000 | 6,251 | 9,983,203 | 10 M to 10 M (+0.15 %) |
| Nov 29 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.44 | 6,000 | 2,650 | 9,968,203 | 10 M to 10 M (+0.06 %) |
| Nov 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.43 | 15,100 | 6,553 | 9,962,203 | 9.9 M to 10 M (+0.15 %) |
| Nov 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.42 | 20,000 | 8,450 | 9,947,103 | 9.9 M to 9.9 M (+0.20 %) |
| Nov 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.44 | 20,000 | 8,750 | 9,927,103 | 9.9 M to 9.9 M (+0.20 %) |
| Nov 09 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.47 | 25,000 | 11,750 | 9,907,103 | 9.9 M to 9.9 M (+0.25 %) |
| Nov 07 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.48 | 55,559 | 26,785 | 9,882,103 | 9.8 M to 9.9 M (+0.57 %) |
| Nov 07 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.46 | 10,000 | 4,550 | 9,826,544 | 9.8 M to 9.8 M (+0.10 %) |
| Nov 02 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.44 | 35,200 | 15,344 | 9,816,544 | 9.8 M to 9.8 M (+0.36 %) |
| Nov 02 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.45 | 100 | 45 | 9,781,344 | 9.8 M to 9.8 M (0.00 %) |
| Nov 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.45 | 19,800 | 8,886 | 9,781,244 | 9.8 M to 9.8 M (+0.20 %) |
| Nov 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.47 | 5,000 | 2,350 | 9,761,444 | 9.8 M to 9.8 M (+0.05 %) |
| Oct 26 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 25,000 | 10,000 | 9,756,444 | 9.7 M to 9.8 M (+0.26 %) |
| Oct 26 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.41 | 31,100 | 12,689 | 9,731,444 | 9.7 M to 9.7 M (+0.32 %) |
| Oct 26 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.43 | 11,000 | 4,720 | 9,700,344 | 9.7 M to 9.7 M (+0.11 %) |
| Oct 26 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.44 | 5,000 | 2,200 | 9,689,344 | 9.7 M to 9.7 M (+0.05 %) |
| Oct 17 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.44 | 27,500 | 12,100 | 9,684,344 | 9.7 M to 9.7 M (+0.28 %) |
| Oct 17 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.42 | 21,000 | 8,822 | 9,656,844 | 9.6 M to 9.7 M (+0.22 %) |
| Oct 17 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.49 | 13,000 | 6,425 | 9,635,844 | 9.6 M to 9.6 M (+0.14 %) |
| Oct 09 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.48 | 4,000 | 1,924 | 9,622,844 | 9.6 M to 9.6 M (+0.04 %) |
| Oct 09 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.46 | 10,000 | 4,600 | 9,618,844 | 9.6 M to 9.6 M (+0.10 %) |
| Oct 09 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.50 | 20,000 | 10,040 | 9,608,844 | 9.6 M to 9.6 M (+0.21 %) |
| Oct 04 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.46 | 25,000 | 11,450 | 9,588,844 | 9.6 M to 9.6 M (+0.26 %) |
| Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.52 | 12,500 | 6,475 | 9,563,844 | 9.6 M to 9.6 M (+0.13 %) |
| Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.50 | 7,000 | 3,530 | 9,551,344 | 9.5 M to 9.6 M (+0.07 %) |
| Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.47 | 15,000 | 7,100 | 9,544,344 | 9.5 M to 9.5 M (+0.16 %) |
| Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.47 | 2,000 | 940 | 9,529,344 | 9.5 M to 9.5 M (+0.02 %) |
| Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.51 | 15,000 | 7,673 | 9,527,344 | 9.5 M to 9.5 M (+0.16 %) |
| Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.40 | 62 | 25 | 9,512,344 | 9.5 M to 9.5 M (0.00 %) |
| Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.51 | 2,000 | 1,020 | 9,512,282 | 9.5 M to 9.5 M (+0.02 %) |
| Sep 26 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 3.00 | 10,000 | 29,950 | 3,687,142 | 3.7 M to 3.7 M (+0.27 %) |
| Sep 26 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.98 | 45,000 | 134,258 | 3,677,142 | 3.6 M to 3.7 M (+1.24 %) |
| Sep 19 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.79 | 2,000 | 5,579 | 3,632,142 | 3.6 M to 3.6 M (+0.06 %) |
| Sep 19 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 2.94 | 3,100 | 9,106 | 3,630,142 | 3.6 M to 3.6 M (+0.09 %) |
| Sep 07 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 3.05 | 3,000 | 9,150 | 3,627,042 | 3.6 M to 3.6 M (+0.08 %) |
| Sep 07 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 3.08 | 15,000 | 46,175 | 3,624,042 | 3.6 M to 3.6 M (+0.42 %) |
| Sep 05 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.92 | 16,500 | 48,197 | 3,609,042 | 3.6 M to 3.6 M (+0.46 %) |
| Sep 05 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.84 | 12,000 | 34,120 | 3,592,542 | 3.6 M to 3.6 M (+0.34 %) |
| Aug 30 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.88 | 6,000 | 17,267 | 3,580,542 | 3.6 M to 3.6 M (+0.17 %) |
| Aug 30 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.82 | 3,000 | 8,467 | 3,574,542 | 3.6 M to 3.6 M (+0.08 %) |
| Aug 30 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.85 | 31,059 | 88,503 | 3,571,542 | 3.5 M to 3.6 M (+0.88 %) |
| Aug 24 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.80 | 5,000 | 13,995 | 3,540,483 | 3.5 M to 3.5 M (+0.14 %) |
| Aug 21 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.87 | 3,000 | 8,609 | 3,535,483 | 3.5 M to 3.5 M (+0.08 %) |
| Aug 21 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.96 | 37,100 | 109,694 | 3,532,483 | 3.5 M to 3.5 M (+1.06 %) |
| Aug 17 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 3.06 | 7,000 | 21,431 | 3,495,383 | 3.5 M to 3.5 M (+0.20 %) |
| Aug 17 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.98 | 10,900 | 32,470 | 3,488,383 | 3.5 M to 3.5 M (+0.31 %) |
| Aug 15 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.99 | 57,969 | 173,113 | 3,477,483 | 3.4 M to 3.5 M (+1.70 %) |
| Aug 15 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.89 | 6,200 | 17,906 | 3,419,514 | 3.4 M to 3.4 M (+0.18 %) |
| Aug 13 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.91 | 14,000 | 40,751 | 3,413,314 | 3.4 M to 3.4 M (+0.41 %) |
| Aug 13 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.92 | 10,000 | 29,171 | 3,399,314 | 3.4 M to 3.4 M (+0.30 %) |
| Aug 08 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.97 | 50,000 | 148,665 | 3,389,314 | 3.3 M to 3.4 M (+1.50 %) |
| Aug 08 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.70 | 64,500 | 174,453 | 3,339,314 | 3.3 M to 3.3 M (+1.97 %) |
| Aug 08 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.69 | 5,000 | 13,430 | 3,274,814 | 3.3 M to 3.3 M (+0.15 %) |
| Aug 01 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 3.00 | 1,000 | 3,000 | 3,269,814 | 3.3 M to 3.3 M (+0.03 %) |
| Aug 01 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.91 | 19,700 | 57,364 | 3,268,814 | 3.2 M to 3.3 M (+0.61 %) |
| Aug 01 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.86 | 22,000 | 63,028 | 3,249,114 | 3.2 M to 3.2 M (+0.68 %) |
| Aug 01 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.80 | 10,000 | 27,955 | 3,227,114 | 3.2 M to 3.2 M (+0.31 %) |
| Aug 01 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.74 | 10,300 | 28,250 | 3,217,114 | 3.2 M to 3.2 M (+0.32 %) |
| Jul 27 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.67 | 30,000 | 80,103 | 3,193,971 | 3.2 M to 3.2 M (+0.95 %) |
| Jul 27 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.65 | 15,000 | 39,677 | 3,163,971 | 3.1 M to 3.2 M (+0.48 %) |
| Jul 27 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.69 | 9,900 | 26,622 | 3,148,971 | 3.1 M to 3.1 M (+0.32 %) |
| Jul 25 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.72 | 11,900 | 32,381 | 3,139,071 | 3.1 M to 3.1 M (+0.38 %) |
| Jul 25 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.72 | 10,000 | 27,189 | 3,127,171 | 3.1 M to 3.1 M (+0.32 %) |
| Jul 16 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.72 | 13,061 | 35,484 | 3,071,313 | 3.1 M to 3.1 M (+0.43 %) |
| Jul 16 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.61 | 36,461 | 95,054 | 3,058,252 | 3 M to 3.1 M (+1.21 %) |
| Jul 19 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.59 | 12,482 | 32,267 | 3,117,171 | 3.1 M to 3.1 M (+0.40 %) |
| Jul 19 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.58 | 33,376 | 86,117 | 3,104,689 | 3.1 M to 3.1 M (+1.09 %) |
| Jul 12 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.63 | 17,300 | 45,558 | 3,021,791 | 3 M to 3 M (+0.58 %) |
| Jul 12 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.81 | 10,000 | 28,140 | 3,004,491 | 3 M to 3 M (+0.33 %) |
| Jul 09 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.97 | 25,000 | 74,173 | 2,994,491 | 3 M to 3 M (+0.84 %) |
| Jul 09 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.91 | 25,000 | 72,873 | 2,969,491 | 2.9 M to 3 M (+0.85 %) |
| Jul 09 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.94 | 25,000 | 73,470 | 2,944,491 | 2.9 M to 2.9 M (+0.86 %) |
| Aug 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.51 | 10,000 | 5,050 | 9,510,282 | 9.5 M to 9.5 M (+0.11 %) |
| Aug 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.50 | 10,000 | 5,000 | 9,500,282 | 9.5 M to 9.5 M (+0.11 %) |
| Aug 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.59 | 10,000 | 5,850 | 9,490,282 | 9.5 M to 9.5 M (+0.11 %) |
| Aug 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.53 | 2,200 | 1,174 | 9,480,282 | 9.5 M to 9.5 M (+0.02 %) |
| Aug 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.54 | 5,000 | 2,722 | 9,478,082 | 9.5 M to 9.5 M (+0.05 %) |
| Jun 29 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.65 | 58,261 | 154,648 | 2,919,491 | 2.9 M to 2.9 M (+2.04 %) |
| Jun 29 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.75 | 100,000 | 274,920 | 2,861,230 | 2.8 M to 2.9 M (+3.62 %) |
| Jun 29 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.56 | 120,000 | 307,596 | 2,761,230 | 2.6 M to 2.8 M (+4.54 %) |
| Jun 29 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.55 | 25,000 | 63,750 | 2,641,230 | 2.6 M to 2.6 M (+0.96 %) |
| Jun 27 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.61 | 41,221 | 107,463 | 2,616,230 | 2.6 M to 2.6 M (+1.60 %) |
| Jun 27 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.48 | 135,000 | 335,300 | 2,575,009 | 2.4 M to 2.6 M (+5.53 %) |
| Jun 27 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.53 | 50,000 | 126,250 | 2,440,009 | 2.4 M to 2.4 M (+2.09 %) |
| Jun 27 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.50 | 50,000 | 124,940 | 2,390,009 | 2.3 M to 2.4 M (+2.14 %) |
| Jun 22 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.75 | 6,000 | 16,487 | 2,340,009 | 2.3 M to 2.3 M (+0.26 %) |
| Jun 22 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.73 | 12,000 | 32,766 | 2,334,009 | 2.3 M to 2.3 M (+0.52 %) |
| Jun 19 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.76 | 1,900 | 5,236 | 2,322,009 | 2.3 M to 2.3 M (+0.08 %) |
| Jun 19 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.74 | 5,000 | 13,681 | 2,320,109 | 2.3 M to 2.3 M (+0.22 %) |
| Jun 19 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.82 | 15,000 | 42,279 | 2,315,109 | 2.3 M to 2.3 M (+0.65 %) |
| Jun 14 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.84 | 5,000 | 14,187 | 2,300,109 | 2.3 M to 2.3 M (+0.22 %) |
| Jun 14 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.85 | 22,500 | 64,202 | 2,295,109 | 2.3 M to 2.3 M (+0.99 %) |
| Jun 12 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.88 | 4,000 | 11,520 | 2,272,610 | 2.3 M to 2.3 M (+0.18 %) |
| Jun 12 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.80 | 10,000 | 28,010 | 2,268,610 | 2.3 M to 2.3 M (+0.44 %) |
| Jun 04 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 3.10 | 5,148 | 15,957 | 2,258,610 | 2.3 M to 2.3 M (+0.23 %) |
| May 30 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.97 | 6,000 | 17,800 | 2,253,462 | 2.2 M to 2.3 M (+0.27 %) |
| May 30 2007 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 2.98 | 3,000 | 8,942 | 2,247,462 | 2.2 M to 2.2 M (+0.13 %) |
| Apr 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 1.04 | 25,000 | 26,045 | 9,164,754 | 9.1 M to 9.2 M (+0.27 %) |
| Apr 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.78 | 13,500 | 10,504 | 9,139,754 | 9.1 M to 9.1 M (+0.15 %) |
| Apr 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.78 | 10,000 | 7,825 | 9,126,254 | 9.1 M to 9.1 M (+0.11 %) |
| Apr 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.63 | 41,000 | 25,650 | 9,116,254 | 9.1 M to 9.1 M (+0.45 %) |
| Apr 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.61 | 20,000 | 12,176 | 9,075,254 | 9.1 M to 9.1 M (+0.22 %) |
| Jul 20 2006 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | C | 0.50 | 4,300,000 | 2,150,000 | 0 | |
| Jul 20 2006 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | C | 0.50 | 4,300,000 | 2,150,000 | 4,402,042 | 102 K to 4.4 M (+4,213.95 %) |
| Jul 19 2006 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.50 | 2,150,000 | 1,075,000 | 2,150,000 | |
| Jul 19 2006 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 1.00 | 2,150,000 | 2,150,000 | 0 | |
| Jul 19 2006 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.50 | 2,150,000 | 1,075,000 | 4,300,000 | |
| Jul 19 2006 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 1.00 | 2,150,000 | 2,150,000 | 0 |
Page: 1